胃肠外科医师

教育与工作经历：

2010.09-2015.06    中山大学，中山医学院，临床医学，学士。

2015.08-2020.06    中山大学，附属第六医院，外科学，博士，导师：骆衍新。

2020.08-2022.10   中山大学，附属第六医院，基础医学，博士后，合作导师：黄美近。

2020.08-2023.07   中山大学，附属第六医院  住院医师规范化培训（外科）

2023.09-至今     南方医科大学深圳医院，胃肠外科医师

海外经历：

2016.10-2019.08    美国加州大学戴维斯分校，生物化学与分子医学实验室，访问学者，

PI：Hong-Wu Chen。

研究方向：结直肠癌DNA甲基化

已发表学术论文：

# Co-first author

1. Chen Z^#, Huang Z^#, Luo Y, Zou Q, Bai L, Tang G, Wang X, Cao G, Huang M, Xiang J, Yu H. Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer. Journal of Translational Medicine. 2021.

2. Cai D^#, Huang ZH^#, Yu HC, Wang XL, Bai LL, Tang GN, Peng SY, Li YJ, Huang MJ, Cao GW, Wang JP, Luo YX. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer. World Journal of Gastroenterology. 2019.

3. Huang Z, Wang X, Zou Q, Zhuang Z, Xie Y, Cai D, Bai L, Tang G, Huang M, Luo Y, Yu H. High platelet-to-lymphocyte ratio predicts improved survival outcome for perioperative NSAID use in patients with rectal cancer. International Journal of Colorectal Disease. 2020.

4. Zhang X, Huang Z, Wang J, Ma Z, Yang J, Corey E, Evans CP, Yu AM, Chen HW. Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling. Cancers. 2021.

5. Wang Y, Huang Z, Chen CZ, Liu C, Evans CP, Gao AC, Zhou F, Chen HW. Therapeutic targeting MDR1 expression by RORγ antagonists resensitizes cross-resistant CRPC to taxane via coordinated induction of cell death programs. Molecular Cancer Therapeutics. 2019.